Literature DB >> 2117186

Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderly.

N Debbas1, J P Derenne.   

Abstract

The effect of an immunostimulating drug, OM-85 BV, was demonstrated on recurrent infection rates in 265 elderly patients with a defined state of chronic bronchitis, during a 6-month, double-blind, placebo-controlled trial. Patients receiving OM-85 BV presented less infections (p = 0.005) and a significantly reduced intake of antibiotics (p = 0.02) as compared to those receiving a placebo and the antibiotic intake was significantly reduced (p = 0.02).

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2117186     DOI： 10.1007/bf02718202

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


  4 in total

1.  [Effect of an oral polyvalent bacterial lysate (Broncho-Vaxom) in chronic bronchitis].

Authors:  R Keller; G Hinz
Journal:  Prax Klin Pneumol       Date:  1984-06

2.  Immunoglobulin production in man stimulated by an orally administered bacterial lysate.

Authors:  J M Puigdollers; G R Serna; I Hernandez del Rey; M T Barruffet; J J Torroella
Journal:  Respiration       Date:  1980       Impact factor: 3.580

3.  [Effect of a bacterial lysate (Broncho-Vaxom) in the therapy of chronic bronchitis: multi-center double-blind clinical trial].

Authors:  C Messerli; F Michetti; P Sauser-Hall; C Stäubli; M Taddei; S Weiss; J C Farine; T Fux
Journal:  Rev Med Suisse Romande       Date:  1981-02

4.  Clinical and immunobiological effects of an orally administered bacterial extract.

Authors:  G J Maestroni; G A Losa
Journal:  Int J Immunopharmacol       Date:  1984
  4 in total
  6 in total

1.  Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines.

Authors:  M Roth; L H Block
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  Changes in cytokine and nitric oxide secretion by rat alveolar macrophages after oral administration of bacterial extracts.

Authors:  E Broug-Holub; J H Persoons; K Schornagel; G Kraal
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

3.  Prevention of infection in immunosuppressive patients with autoimmune nephrosis by using an immunostimulating bacterial lysate Broncho-vaxom.

Authors:  Miao Zhang; Hong Luan; Qian Zhang; Le Wang; Yong-Man Lv; Fan He; Yan Chen; Hong-Bing Zeng; Ying Yao; Qin Liu
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

4.  May we strengthen the human natural defenses with bacterial lysates?

Authors:  Elisa Villa; Valentina Garelli; Fulvio Braido; Giovanni Melioli; Giorgio Walter Canonica
Journal:  World Allergy Organ J       Date:  2010-08       Impact factor: 4.084

5.  Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.

Authors:  F Braido; F Tarantini; V Ghiglione; G Melioli; G W Canonica
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

6.  Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance.

Authors:  Gianmarco Troiano; Gabriele Messina; Nicola Nante
Journal:  J Prev Med Hyg       Date:  2021-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.